London Stock Exchange welcomes Astrazeneca to celebrate 25 years of scientific innovation and Q4 & full year 2023 financial results

AstraZeneca (AZN) celebrates its 25th anniversary and Q4 & full year 2023 financial results today with CEO Pascal Soriot and CFO Aradhana Sarin joining employees from across the pharmaceutical company at the London Stock Exchange to open the market.

The team celebrating on the balcony at LSEG during the welcome ceremony.

Established in 1999 through the merger of Sweden’s Astra AB (Astra) and the UK’s Zeneca Group PLC (Zeneca), AstraZeneca has grown to become one of the largest companies on the FSTE100 by market capitalisation. Today, the company operates in over 130 countries, with more than 83,000 employees globally and supplies life-saving medicines to millions of patients around the world.

With a relentless focus on pushing the boundaries of science to deliver new medicines, the company today also underlined the progress being made on its long-term growth strategy with the announcement of its Q4 & Full Year 2023 financial results.

Useful links

Check out what's happening at the Exchange

Looking to find out more about accessing capital?

If you'd like to find out more about accessing capital, please submit your details and a member of our team will be in touch.

By submitting this form, you agree to your personal data being shared within the London Stock Exchange Group of companies (LSEG) for the purpose of receiving communications via post, phone and electronic means from LSEG about events, resources, products, and/or services.

For more information on how LSEG uses your data, see our privacy statement. You can adjust your preferences at any time through the preference link in any electronic communication that you receive from us.